Who Is Atul Gawande? Surgeon, Author & Public Health Leader

Atul Gawande is a surgeon, public health leader, and bestselling author whose work has shaped how hospitals around the world approach safety, end-of-life care, and health systems design. He served as Assistant Administrator for Global Health at the U.S. Agency for International Development (USAID) during the Biden administration, and before that spent decades as a practicing surgeon at Brigham and Women’s Hospital and a professor at both Harvard Medical School and the Harvard School of Public Health.

Early Education and Training

Gawande earned a bachelor’s degree from Stanford University in 1987, then studied at the University of Oxford as a Rhodes Scholar, completing a master’s degree in 1989. He went on to earn his medical degree and a master’s in public health. His surgical residency at Brigham and Women’s Hospital in Boston became source material for his first book, where he wrote candidly about the process of learning to operate on people and the errors that inevitably accompany that learning curve.

Surgical Career and Clinical Work

Gawande practiced as a general and endocrine surgeon at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, both in Boston. His clinical experience became inseparable from his broader mission: understanding why medical systems fail patients and how to fix them. Rather than focusing narrowly on his own operating room, he studied patterns across surgical care, including the rapid rise of bariatric surgery and the unacceptable rates of death and complications it produced in certain facilities.

The Surgical Safety Checklist

Gawande’s most concrete contribution to global medicine may be the WHO Surgical Safety Checklist, a simple tool designed to prevent common, preventable errors in the operating room. The concept was straightforward: before making an incision, the surgical team pauses to confirm the patient’s identity, the correct surgical site, allergies, and anticipated risks. It sounds obvious, but the results were dramatic.

A landmark study led by Haynes and colleagues found that implementing the checklist cut rates of in-hospital death, surgical site infections, and reoperation by nearly half. Broader reviews confirmed the pattern, with one study showing complication rates dropping from 15.4% to 10.6% and corresponding reductions in hospital mortality. The checklist has since been adopted in operating rooms worldwide. It also inspired Gawande’s 2009 book, The Checklist Manifesto, which argued that simple, process-driven tools could prevent failures in complex systems far beyond medicine.

Ariadne Labs

In 2012, Gawande co-founded Ariadne Labs with surgeon Bill Berry as a joint center for health systems innovation housed at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health. The lab started with 13 employees and a core insight from Gawande’s checklist work: simple tools like checklists, coaching, and data feedback could save lives at scale.

The lab’s scope expanded as the team recognized that communication gaps between patients and clinicians were causing as much harm as procedural errors. This led to the development of the Serious Illness Conversation Guide, a structured framework that helps doctors have better conversations with patients facing life-threatening conditions. During the COVID-19 pandemic, Ariadne Labs also focused on strengthening primary care systems and connecting clinical resources to community health needs.

Writing for a General Audience

Gawande has been a staff writer at The New Yorker for more than two decades, covering surgery, public health, and the systems that determine whether patients live or die. His writing style blends personal narrative with rigorous reporting, often drawing from his own patients and clinical experiences to illustrate systemic problems.

He has published four major books. Complications (2002) explored the messy reality of surgical training and medical error. Better (2007) examined what separates good medical performance from great. The Checklist Manifesto (2009) made the case for structured protocols in high-stakes environments. And Being Mortal (2014), his most widely read book, tackled end-of-life care in a way that reached far beyond medical professionals.

The Impact of Being Mortal

Being Mortal argued that modern medicine had become so focused on extending life at any cost that it routinely failed dying patients. Gawande wrote that contemporary culture had evaded any meaningful conversation with patients and families about well-being during their final days, and that the medical system’s default toward aggressive, often futile treatments was causing unnecessary suffering.

The book offered a different vision. In one passage, Gawande described how hospice care for his daughter’s piano teacher brought pain relief, a return home, and enough clarity for her to decide how she wanted to spend her remaining time. He encouraged doctors to pause before recommending another treatment and instead ask patients what a good life looks like for them, even as it approaches its end. The book became a bestseller and shifted how many clinicians and families approach these conversations, making palliative care more visible as a legitimate, humane choice rather than a last resort.

Haven: The Amazon-Berkshire-JPMorgan Venture

In 2018, Gawande was named CEO of Haven, a health care venture created by Jeff Bezos, Warren Buffett, and Jamie Dimon to reduce costs and improve care for their companies’ employees. It was one of the most closely watched experiments in American health care, and it struggled. Gawande was transparent about his lack of business experience, telling employees at weekly meetings that he was learning basic startup concepts on the job.

The venture faced high turnover in its leadership team, with three of six senior leaders departing within a year. Its operations overlapped with Amazon’s own parallel health care efforts, and the three founding CEOs were not deeply involved in day-to-day guidance, leaving Gawande to reconcile the differing cultures of three massive corporations. He stepped down as CEO in 2020, moving to a board advisory role and citing a desire to focus on policy work related to COVID-19. Haven itself dissolved shortly after. Several business and health care leaders said they had long doubted that even someone of Gawande’s reputation could handle the operational demands of running a health care startup without prior business experience.

Global Health Leadership at USAID

Gawande was confirmed as USAID’s Assistant Administrator for Global Health during the Biden administration. In his Senate confirmation testimony, he outlined three priorities: controlling COVID-19, preparing for the next pandemic, and strengthening global health systems to recover ground lost in life expectancy gains during the pandemic years. The role put him in charge of one of the world’s largest global health portfolios, overseeing programs in HIV/AIDS, maternal and child health, malaria, tuberculosis, and nutrition across dozens of countries.

Awards and Recognition

Gawande received a MacArthur Fellowship in 2006, often called a “genius grant,” recognizing his dual contributions as a surgeon and writer. He was also a Rhodes Scholar early in his career. His combination of clinical practice, institutional leadership, policy work, and popular writing has made him one of the most publicly visible physicians in the United States, someone whose influence extends well beyond the patients he has personally treated.